Part 5/10:
One critical issue scrutinized was the lengthy drug approval process. The current system, taking over a decade, hampers timely access to potentially life-saving medications. The administration's challenge is to reimagine and reform this pipeline to reduce approval times without compromising safety and efficacy, thereby maximally benefiting patients in need.